Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
Listen now
Description
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
More Episodes
Jonathan Bricker, professor in the cancer prevention program at Fred Hutchinson Cancer Center, on how to quit smoking with help from tech and biotech tools.
Published 11/25/24
Leslie Williams, CEO of Boston-based hC Bioscience, on developing transfer RNA therapies.
Published 11/06/24